surmount-4 tirzepatide withdrawal weight regain In the trial, 82.5% of adults with obesity regained ≥25% of initial lost within one year of withdrawal; most showed reversal of cardiometabolic improvements. https://t.co/eX8xLaKaS6 Continued Treatment With Tirzepatide for
Description
Your healthcare provider may lower your dose of insulin or sulfonylureas to reduce this risk
Consider seeing a dermatologist: A specialist can offer personalized treatment
The statements and products listed on this website are not intended to diagnose, treat, cure, or prevent any disease.
Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context
These include: Lower calorie intake: Tirzepatide can significantly reduce appetite and, in turn, calorie intake
